Found 11 resultsAuthor [ Title] Type Year
Filters: Author is Treanor, John J [Clear All Filters]
Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis, 202(11), 1649-58. presented at the 2010 Dec 01. doi:10.1086/657087. (2010).
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine. Clin Vaccine Immunol, 24(5). presented at the 2017 May. doi:10.1128/CVI.00571-16. (2017).
Dose-dependent neutralizing-antibody responses to vaccinia. J Infect Dis, 189(3), 493-7. presented at the 2004 Feb 01. doi:10.1086/380906. (2004).
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis, 193(9), 1223-8. presented at the 2006 May 01. doi:10.1086/503050. (2006).
Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis, 197(4), 580-3. presented at the 2008 Feb 15. doi:10.1086/526537. (2008).
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis, 198(5), 635-41. presented at the 2008 Sep 01. doi:10.1086/590916. (2008).
Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. J Infect Dis, 211(6), 870-8. presented at the 2015 Mar 15. doi:10.1093/infdis/jiu497. (2015).
A novel intramuscular bivalent norovirus virus-like particle vaccine candidate--reactogenicity, safety, and immunogenicity in a phase 1 trial in healthy adults. J Infect Dis, 210(11), 1763-71. presented at the 2014 Dec 01. doi:10.1093/infdis/jiu337. (2014).
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine, 27(37), 5091-5. presented at the 2009 Aug 13. doi:10.1016/j.vaccine.2009.06.057. (2009).
Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial. J Infect Dis, 198(9), 1309-16. presented at the 2008 Nov 01. doi:10.1086/592172. (2008).
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med, 354(13), 1343-51. presented at the 2006 Mar 30. doi:10.1056/NEJMoa055778. (2006).